Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Insight into the biomarkers as the novel anti-psoriatic drug discovery tool: a contemporary viewpoint.

Rahman M, Zaki Ahmad M, Kazmi I, Akhter S, Beg S, Gupta G, Afzal M, Saleem S, Ahmad I, Adil Shaharyar M, Jalees Ahmed F, Anwar F.

Curr Drug Discov Technol. 2012 Mar;9(1):48-62. Review.

PMID:
22023258
2.

A comprehensive review of biomarkers in psoriasis.

Rashmi R, Rao KS, Basavaraj KH.

Clin Exp Dermatol. 2009 Aug;34(6):658-63. doi: 10.1111/j.1365-2230.2009.03410.x. Epub 2009 Jun 25. Review.

PMID:
19558584
3.

Integrative clinical transcriptomics analyses for new therapeutic intervention strategies: a psoriasis case study.

Qu XA, Freudenberg JM, Sanseau P, Rajpal DK.

Drug Discov Today. 2014 Sep;19(9):1364-71. doi: 10.1016/j.drudis.2014.03.015. Epub 2014 Mar 21. Review.

PMID:
24662034
4.

Bio-markers as tools for discovery of new psoriasis therapies.

Braddock M.

Curr Drug Discov Technol. 2012 Mar;9(1):1. No abstract available.

PMID:
22375918
5.

A pathogenetic approach to autoimmune skin disease therapy: psoriasis and biological drugs, unresolved issues, and future directions.

Ayroldi E, Bastianelli A, Cannarile L, Petrillo MG, Delfino DV, Fierabracci A.

Curr Pharm Des. 2011;17(29):3176-90. Review.

PMID:
21864268
6.

Oral tazarotene and oral pimecrolimus: novel oral therapies in development for psoriasis.

Singh F, Weinberg JM.

J Drugs Dermatol. 2004 Mar-Apr;3(2):141-3. Review.

PMID:
15098968
7.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
8.

Psoriasis clinical implications and treatment: a review.

Raut AS, Prabhu RH, Patravale VB.

Crit Rev Ther Drug Carrier Syst. 2013;30(3):183-216. Review.

PMID:
23614646
9.

Psoriasis drug discovery: methods for evaluation of potential drug candidates.

Svensson L, Røpke MA, Norsgaard H.

Expert Opin Drug Discov. 2012 Jan;7(1):49-61. doi: 10.1517/17460441.2011.632629. Epub 2011 Nov 8. Review.

PMID:
22468893
10.

Psoriasis and psoriatic arthritis: separate or one and the same?

Ciocon DH, Kimball AB.

Br J Dermatol. 2007 Nov;157(5):850-60. Epub 2007 Aug 24. Review.

PMID:
17725671
11.

Molecular mechanisms of tazarotene action in psoriasis.

Duvic M, Nagpal S, Asano AT, Chandraratna RA.

J Am Acad Dermatol. 1997 Aug;37(2 Pt 3):S18-24. Review.

PMID:
9270552
12.

New therapies under development for psoriasis treatment.

García-Pérez ME, Stevanovic T, Poubelle PE.

Curr Opin Pediatr. 2013 Aug;25(4):480-7. doi: 10.1097/MOP.0b013e328362c3f6. Review.

PMID:
23838833
13.

Soluble biomarkers in psoriasis.

Enerbäck C.

Eur J Dermatol. 2011 Nov-Dec;21(6):844-50. doi: 10.1684/ejd.2011.1482. Review.

PMID:
21856557
14.

Psoriasis: targeting therapy towards the inflammatory cascade.

Miteva M.

Am J Clin Dermatol. 2010;11 Suppl 1:11-3. doi: 10.2165/1153414-S0-000000000-00000. Review.

PMID:
20586499
15.

Translating clinical activity and gene expression signatures of etanercept and ciclosporin to the psoriasis xenograft SCID mouse model.

Norsgaard H, Svensson L, Hagedorn PH, Moller K, Olsen GM, Labuda T.

Br J Dermatol. 2012 Mar;166(3):649-52. doi: 10.1111/j.1365-2133.2011.10713.x. Epub 2012 Jan 19.

PMID:
22050597
16.

Novel drug delivery systems in topical treatment of psoriasis: rigors and vigors.

Katare OP, Raza K, Singh B, Dogra S.

Indian J Dermatol Venereol Leprol. 2010 Nov-Dec;76(6):612-21. doi: 10.4103/0378-6323.72451. Review.

17.

Long-term efficacy of biologics in the treatment of psoriasis: what do we really know?

Alwawi EA, Krulig E, Gordon KB.

Dermatol Ther. 2009 Sep-Oct;22(5):431-40. doi: 10.1111/j.1529-8019.2009.01259.x. Review.

PMID:
19845720
18.

Use of biologic agents in pediatric psoriasis.

Marji JS, Marcus R, Moennich J, Mackay-Wiggan J.

J Drugs Dermatol. 2010 Aug;9(8):975-86. Review.

PMID:
20684148
19.

Biological biomarkers in psoriatic disease. A review.

de Vlam K, Gottlieb AB, Fitzgerald O.

J Rheumatol. 2008 Jul;35(7):1443-8. Review.

PMID:
18609742
20.

Antipsoriatic drug development: challenges and new emerging therapies.

García-Pérez ME, Jean J, Pouliot R.

Recent Pat Inflamm Allergy Drug Discov. 2012 Jan;6(1):3-21. Review.

PMID:
22022925

Supplemental Content

Support Center